Mr. Vincent has over 25 years of experience in strategic and operational planning and finance; private and public offerings in early stage private start-ups through mature large-size international public companies across multiple industries. He has held senior management positions at Genoa Pharmaceuticals (co-founder), Zavante Therapeutics, Meritage Pharma, Sorrento Therapeutics, Elevation Pharmaceuticals, Suneva Medical, Verus Pharmaceuticals, Women First HealthCare, Elan Pharmaceuticals, Phase Metrics, and Deloitte & Touche LLP, where he specialized in emerging growth and publicly-reporting companies.

Over the past 20 years, Mr. Vincent’s experience includes raising over $650 million through venture capital, crossover investors, major commercial banks and institutions, and public offering proceeds for high growth pharmaceutical and technology-based companies, and participating in a number of acquisitions, divestitures and license activities valued at over $2 billion. Mr. Vincent was named 2014 public company CFO of the Year in San Diego by the San Diego Business Journal. He became a Certified Public Accountant in California and holds a B.S. degree in business from San Diego State University.